DOUG’S VARIN™ -- LONG AWAITED RARE THCV CANNABIS FORMULATION – HITS THE MARKET EXCLUSIVELY AT SPARC™ NORTHERN CALIFORNIA LOCATIONS
OAKLAND, CA, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Doug’s Varin™-- a rare and highly sought-after cannabis formulation which contains the highest concentrations of THCV(tetrahydrocannabivarin)– is now available for sale in limited quantities at SPARC’s five dispensaries located in San Francisco, Santa Rosa and Sebastopol.
|
|||||||||
This first limited distribution will include two THCV-rich vape pen product lines: Doug’s Varin ORIGINAL and Doug’s Varin RELIEF. Both contain 25%-30% THCV cannabis oil,found naturally in the resin-glands of rare cannabis flowers, and are reputed to offer possible long-awaited personal health benefits. The high THCV levels are enough to activate the compound’s surprising effects.
“We are thrilled to partner with SPARC to offer for the first time our new line of Doug’s Varin products in the San Francisco Bay area,” said David Lampach, CEO of California Cannabinoids, Inc. “Doug’s Varin contains the highest levels of THCV currently in the marketplace, offering cannabis consumers the possibility of exciting, new health benefits.”
“We know there is a strong consumer demand for Doug’s Varinand its unique THCV offering,” said Erich Pearson, CEO of SPARC. “We look forward to being the first to offer consumers access to this highly awaited cannabis product.”
California Cannabinoids, Inc. will announce additional product availability in the coming months, along with new Doug’s Varin product lines and licensing agreements. For more information on initial retail locations, product offerings and licensing opportunities, please visit www.dougsvarin.comand www.sparcsf.com.
# # #
About Doug’s Varin and California Cannabinoids, Inc.: Formed in 2017, California Cannabinoids, Inc. is a California corporation based in Oakland, with the mission of providing the cannabis industry and consumers access to rare cannabinoids. The company is the exclusive provider of Doug’s Varin™ which contains the highest concentrations of tetrahydrocannabivarin (THCV) currently available in the marketplace. CEO David Lampach is a long-time industry expert, grower and advocate for clean, safe cannabis. Prior to founding California Cannabinoids, he was Co-Founder and CEO of Steep Hill Labs and served a consultant to several states concerning the creation and implementation of various aspects of medical and recreational cannabis regulation. To learn more, visit: DougsVarin.com.
About SPARC: Founded by Erich Pearson in 2010 as a nonprofit medical cannabis dispensary dedicated to providing safe, consistent, and affordable medical cannabis to patients and for adult use, the SPARC family of dispensaries is a trusted source of cannabis products for discerning individuals seeking to enhance their quality of life through mindful cannabis use. Built on the mission of San Francisco Cannabis Collective, SPARC fills the needs of qualified low-income patients whose doctors have prescribed medical marijuana to address serious illnesses. SPARC also collaborates with local hospices, residential care facilities, and dispensaries to successfully supply medical marijuana at no cost to seriously ill patients. With five retail cannabis dispensaries, three in San Francisco with its new Love Shack and two in Sonoma County, SPARC is known as an industry leader and innovator promoting an intelligent approach to cannabis cultivation, production, distribution, and use as these expand to meet the needs of a broader audience. To learn more, visit: sparcsf.org.
Attachments
Kevin Herglotz HPA Strategic Communications 415-963-2601 kevin@hpastrategies.com Michael Coats SPARC Communications 415-794-6669 Michael@coatsPR.com Michael Farkas SPARC Communications 415-794-6669 mfarkas@sparcpr.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
